OBJECTIVE: To investigate the incidence of off-label (OL) and unlicensed (UL) prescribing to children in primary care in Malta.
METHODS: A prospective pharmaco-epidemiological review of 1507 medicines recommended to 924 children by both paediatricians and general practitioners was conducted. OL medicines were defined as medicines that were not prescribed in accordance with their Summary of Product Characteristics (SmPC) with respect to age, dose and indication as well as frequency, duration and route of administration. UL medicines were defined as medicines that did not have a marketing authorisation, as well as medicines whose formulation was modified.
RESULTS: 721 from 1507 medicines (47.8% ) were prescribed in an OL/UL manner, the highest incidence in the 1 month –2 years age range (210 from 345 medicines; 60.9% ). More paediatricians rather than family doctors prescribed in an UL (11.6% vs 3.6% , p < 0.001) and OL manner for age (25.7% vs 19.6% , p < 0.001). Conversely, more family doctors rather than paediatricians prescribed in an OL manner for dose (33.5% vs 21.4% , p < 0.001).
CONCLUSION: Contributing factors for the high rates of OL and UL prescribing include failure by prescribers to follow recommendations detailed in the product literature and a lack of licensed paediatric medicines.
European Commission2008Child Poverty and well-being in the EUCurrent Status and way forwardLuxembourgOffice for Official Publications of the European Communities
2.
Federal Interagency Forum on Child and Family Statistics. America’s Children: Key National Indicators of Well-Being. US Government Printing Office: Washington; 2013. Cited 2014 June 21.Available from: http://childstats.gov/americaschildren/glance.asp
3.
AvornA2012Two centuries of assessing drug risksN Eng J Med3673193197
4.
PandolfiniCBonatiM2005A literature review on off-label drug use in childrenEur J Pediatr164552558
5.
CuzzolinLAtzeiAFanosV2006Off-label and unlicensed prescribingfor newborns and children in different settings: A review of theliterature and a consideration about drug safetyExpert Opin Drug703718Saf 5
6.
KimlandEOdlindV2012Off-label drug use in pediatric patientsClin Pharmacol Ther915796801
7.
KeblerLF1901Habit-forming agents: Their indiscriminate sale and use. A menace to the public welfareWashingtonUS Department of Agriculture
8.
DuffusJHTempletonDMNordbergM2009Concepts in toxicologyCambridgeThe Royal Society of Chemistry
9.
BushA2003Safety of medicines in childrenExpert Opinion on Drug Safety22109112
10.
McIntyreJConroySAveryACornsHChoonaraI2000Unlicensed and off label prescribing of drugs in general practiceArch Dis Child83498501
11.
Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy D. Pediatric Information in Drug Product Labeling [letter]; 2012. Cited 2014 Sep 9. Available from:http://jama.jamanetwork.com/article.aspx?articleid=1151522
12.
ChesneyR2005Children as clinical research subjectsJ Pediatr146579580
13.
WallerDG2007Off-label and unlicensed prescribing for children: Have we made any progress?Br J Clin Pharmacol64112
14.
European Commission2004Regulation on medicines for children: Frequently asked questionsLuxembourgOffice for Official Publications of the European Communities
15.
European Medicines Agency. Evidence of harm from off-label or unlicensed medicines in children. London; 2004. Cited 2014 May 12. Available from: http://www.ema.europa.eu/ema/
16.
NeubertAWongICKBonifaziA2008Defining off-label and unlicensed use of medicines for children: Results of a Delphi surveyPharmacol Res585-6316322
17.
European Medicines Agency. Guideline on good pharmacovigilance practices (GVP). Annex I – definitions; 2012. Cited 2014 May 12. Available from: http://www.ema.europa.eu/ema/
18.
SchirmETobiHde Jongvan den BergLTW2002Unlicensed and off label drug use by children in the community: Cross sectional studyBMJ32413121313
19.
ChalumeauMTréluyerJMSalanaveB2000Off label and unlicensed drug use among French office based paediatriciansArch Dis Child836502505
20.
AufmannRNLockwoodJNationRDCleggDK2008Mathematical thinking and quantitative reasoningBostonHoughton Mifflin Company
21.
KrejcieRVMorganDW1970Determining sample size for research activitiesEducational and Psychological Measurement30607610
22.
EllulICGrechV2014Off-label and unlicensed paediatric prescribing in a community setting: A prospective longitudinal cohort study in MaltaPaediatr Int Child Health3411218
23.
CarnovaleCContiVPerroneV2013Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approachesEur J Pediatr1721216791685
24.
RibeiroMJorgeAMacedoAF2013Off-label drug prescribing in a Portuguese paediatric emergency unitInt J Clin Pharm3513036
25.
BazzanoATMangione-SmithRSchonlauMSuttorpMJBrookRH2009Off-label prescribing to children in the United States outpatient settingAcad Pediatr928188
26.
MühlbauerBJanhsenKPichlerJSchoettlerP2009Off-label use of prescription drugs in childhood and adolescence: An analysis of prescription patterns in GermanyDtsch Arztebl Int10632531
27.
LassJIrsAPisarevHLeinemannTLutsarI2011Off label use of prescription medicines in children in outpatient setting in Estonia is commonPharmacoepidemiol Drug Saf205474481
28.
OlssonJKimlandEPetterssonSOdlindV2011Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care - a nationwide studyActa Paediatr100912721275
29.
LifshitzMGavrilovVGrossmanZ2002Unapproved prescriptionpractices in primary pediatric clinics in Israel: A prospectiveanalysisCurrent Therapeutic Research6312830837
30.
PandolfiniCCampiRClavennaACazzatoTBonatiM2005Italian paediatricians and off-label prescriptions: Loyal to regulatory or guideline standards? Acta Paediatr946753757
31.
American Academy of Pediatrics Committee on Drugs1996Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration: Subject reviewPediatrics981143145
32.
BavdekarSBGogtayNJ2005Unlicensed and off-label drug use in childrenJ Postgrad Med514249252
33.
MarchettiFBuaJVenturaA2007The awareness among paediatricians of off-label prescribing in children: A survey of Italian hospitalsEur J Clin Pharmacol638185
34.
Bradford WD, Turner JL,Williams JW. Off-Label Use of Pharmaceuticals: Trends and Drivers. UGA/GSU/Emory Health Economics Conference; 2014. Cited 2014 Aug 14.
35.
Ekins-DaukesSHelmsPJSimpsonCRTaylorMWMcLayJS2004Off-label prescribing to children in primary care: Retrospective observational studyEur J Clin Pharmacol60349353
36.
KimlandEBergmanULindemalmSBottigerY2007Drug related problems and off-label drug treatment in children as seen at a drug information centreEur J Pediatr166527532
37.
TafuriGTrottaFLeufkensHGMartiniNSaglioccaLTraversaG2009Off-label use of medicines in children: Can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux diseaseEur J Clin Pharmacol652209216
38.
GazarianM2003Why are children still therapeutic orphans?Aust Prescr26122123
39.
Aynsley-GreenA1998What’s to be done about the malaise in science training in paediatrics and child health?Arch Dis Child78104
